Claritas Capital — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Gatehouse Biogatehousebio.cominDec 2020
Gatehouse Bio develops AI-powered therapeutics for pulmonary, cardiac, neurological, and autoimmune diseases by decoding small RNAs using their Code-Breaker platform to design precision medicine treatments.
AI & Machine LearningBiotechMedical DevicesWaltham, US
Neal Foster(Executive Officer, Director)David W. Salzman, Ph.D.(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.